Bristol Myers Squibb chooses Puerto Rico for biotechnological expansion

This article is reproduced by CienciaPR with permission from the original source.

PDF versionPDF version
Cited from March 28, 2006 “Nowadays, Bristol Myers Squibb employs 2,200 people in Puerto Rico, 370 of those in its Manatí plant.” “The fact that they chose Puerto Rico to produce this drug, demonstrates the capabilities of our people to manufacture this type of products.’, said governor Aníbal Acevedo Vilá. The governor said that with the production of Orencia, “Puerto Rico adds another biotechnological manufacture operation to those initiated by Amgen in Juncos, Ortho Biologics in Manatí, Becton Dickinson in Cayey, Abbot in Barceloneta and Lilly in Carolina.”